Hisrological Alterations and Immune Response Induced by Pet Toxin During Colonization with Enteroaggregative Escherichia coil (EAEC) in a Mouse Model Infection

  • Eslava, Carlos (Departmento de Salud Publica. Facultad de Medicina. Universidad Nacional Aut noma de Mexico) ;
  • Sainz, Teresita (Departmento de Sistemas Biolgicos, Division de CBS, Universidad Aut noma Mertropolitana-Xochomilco) ;
  • Perez, Julia (Departmento de Sistemas Biolgicos, Division de CBS, Universidad Aut noma Mertropolitana-Xochomilco) ;
  • Fresan, Ma.Cristina (Departmento de Sistemas Biolgicos, Division de CBS, Universidad Aut noma Mertropolitana-Xochomilco) ;
  • Flores, Veronica (Departmento de Sistemas Biolgicos, Division de CBS, Universidad Aut noma Mertropolitana-Xochomilco) ;
  • Jimenez, Luis (Departmento de Sistemas Biolgicos, Division de CBS, Universidad Aut noma Mertropolitana-Xochomilco) ;
  • Hernandez, Ulises (Departmento de Salud Publica. Facultad de Medicina. Universidad Nacional) ;
  • Herrera, Ismael (Departmento de Anatom a. Facultad de Medicina. Universidad Nacional)
  • 발행 : 2002.06.01

초록

Enteroaggregative E. coil (EAEC) is an important aethiological causal agent of diarrhea in people of developed and undeveloped countries. Different in vitro and in vivo models have been proposed to study the pathdgenic and immune mechanisms of EAEC infaction. The aim of this study was to analyze whether BALB/c mice could be used as an animal model to study EAEC pathogenesis Six-week-old BALB/c mice were inoculated with EAEC strain 042 (044:H88) nalidixic acid resistant, and re-inoc-ulated ten days after. Mice feces were monitored for the presence of the EAEC strain over a period of 20 days . Bacteria were enumerated on MacConkey agar containing 100$\mu$g of nalidixic acid per ml. Results showed that 35% of the animals were colonized for 3 days, 15% for 5 and 10% for more than 7 days . After re-inoculation only 16% of the animals remained colonized for more than 3 days. During the necropsy, the intestinal fluid of same of the infected animals presented mucus and blood. Six of these fluids showed the presence of IgA antibodies againset Pet toxin and IgG natibodies raised against the toxin were also detected in the animal serum. Histopathologic evidence confirms the stimulation of mucus hypersecretion, an increased amount of goblet cells and the presence of bacterial aggregates in the apical surfaces of intestinal epithelial cells. Edema was present in the submucosa. These results suggest that BALB/c mice could be used as an animal model for in vivo study of EAEC infection.

키워드

참고문헌

  1. Anal. Biochem. v.72 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Bradford, M.M. https://doi.org/10.1016/0003-2697(76)90527-3
  2. Can. J. Microbiol. v.44 Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7 Conlan, J.W.;M.B. Perry https://doi.org/10.1139/cjm-44-8-800
  3. Abstr. 93rd Annu. Meet. Am. Soc. Microbiol. Identification of a protein with toxigenic activity produced by enteroaggregative Escherichia coli Eslava, C.;J. Villaseca;R. Morales;A. Navarro;A. Cravioto
  4. Infect. Immun. v.66 Pet, an autotransporter enterotoxin from enteroaggregative Escheichia coli Eslava C.;F. Navarro-Garcia;J.R. Czeczulin;I.R. Henderson;A. Cravioto;J.P. Nataro
  5. infect. Immun. v.60 Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro Hicks, S.;D.C.A. Candy;A.D. Phillips
  6. Nature v.227 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli, U.K.; https://doi.org/10.1038/227680a0
  7. N. Engl. J. Med. v.332 Enteroaggregative Escheichia coli as a possible cause of diarrhea in an HIV-infected patient Mayer, H.B.;C.A. Wanke https://doi.org/10.1056/NEJM199501263320416
  8. J. Clin. Microbio v.36 Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome Morabito, S.;H. Karch;P. Mariani-Kurkjian;H. Schmith;F. Minelli;E. Bingen;A. Carioli
  9. Pediatr. Infect. Dis. J. v.6 Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells Nataro, J.P.;J.B. Kaper;R. Robins-Browne;P. Vial;M.M. Levine https://doi.org/10.1097/00006454-198709000-00008
  10. J. Infect. Dis. v.171 Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers Nataro, J.P.;Deng Yikang;S. Cookson;A. Cravioto;S.J. Savarino;L.D. Guers;M.M. Levine;C.O. Tacket https://doi.org/10.1093/infdis/171.2.465
  11. Emerg. Infect. Dis. v.4 Enteroaggregative Escherichia coli Nataro, J.P.;T. Steiner;R. L. Guerrant https://doi.org/10.3201/eid0402.980212
  12. Clin. Microbiol. Rev. v.11 Diarrheagenic Escherichia coli Nataro, J.P.;J.B. Kaper
  13. Infect. Immun. v.66 In vitro effect of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli Navarro-Garcia, F.;C. Eslava;J.M. Villaseca;R. Lopez-Revilla;J.R. Czeczulin;S. Srinivas;J.P. Nataro;A. Cravioto
  14. Infect. Immun. v.67 Cytoskeletal effects induced by Pet, the serine protease enterotoxin of enteroaggregative Escherichia coli Navarro-Garcia, F.;C. Sears;C. Eslava;A. Cravioto;J.P. Nataro
  15. Indial J. Med. Res. v.106 An eqidemic diarrhea in south India caused by enteroaggregative Escherichia coli Pai, M.;G. Kang;B.S. Ramakrishna;A. Venkataraman;J. Muliyil
  16. J. Clin. Microbiol. v.35 HEp-2 cell adherence patterns, serotyping, and DNA analysis of Escherichia coli isolates from eight patients with AIDS and chronic diarrhea Ploltsky, Y.;J.P. Nataro;D. Kotler;T.J. Barrett;J.M. Orenstein
  17. Infec. Immun. v.62 Host specificity of entheropathogenic Escherichia coli from rabbits: lack of correlation between adherence in vitro and pathogenicity for laboratory animals Robins-Browne, R.M.;A.M. Tokhi;L.M. Adams;V. Bennett-Wood
  18. Rev. Mex. Cien. Farma. v.31 Obtencion de cepas de Escherichia coli enteroagregativas (EAEC) resistentes al acido nalidixico, para suempleo en el establecimiento de infecciones gastrointestinales en modelos animales Sainz, E.T.
  19. Emerg. Infect. Dis. v.3 Multidrug-resistant enteroaggregative Escherichia coli associated with persistent diarrhea in kenyan children Sang, W.K.;J.O. Oundo;J.K. Mwituria;P.G. Waiyaki;M. Yoh;T. Ilida;T. Honda https://doi.org/10.3201/eid0303.970317
  20. Lancet. v.350 Enteroaggregative Escherichia coli and outbreaks of gastroenteritis in UK Smith, H.R.;T. Cheasty;B. Rowe
  21. The Williams & Wilkins Company Staining Procedures used by the Biological Stain Commission
  22. J. Infect. Dis. v.177 Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells Steiner, T.S.;A.A.M. Lima;J.P. Nataro;R.L. Guerrant https://doi.org/10.1086/513809
  23. Proc. Natl. Acad. Sci. v.76 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Towbin, H.;T. Staehelin;J. Gordon https://doi.org/10.1073/pnas.76.9.4350
  24. Infect. Immun v.60 Studies with enteroaggregative Escherichia coli in gnotobiotic piglet gastroenteritis model Tzipori, S.;J. Montanaro, R.M.;Robins-Browne;P. Vial;R. Gibson;M.M. Levine
  25. J. Infect. Dis. v.158 Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease Vial, P.;R. Robins-Browne;H. Lior;V. Prodo;J.B. Kaper;J.P. Nataro;D. Meneval;A. Elsayed;M.M. Levine https://doi.org/10.1093/infdis/158.1.70
  26. Infect. Immun. v.68 Pet toxin from Enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption Villaseca, J.M.;F. Navarro-Garcia;G. Mendoza-Hernandez;J.P. Nataro;A. Cravioto;C. Eslava https://doi.org/10.1128/IAI.68.10.5920-5927.2000
  27. Infect. Immun. v.58 Characterization of binding of Escherichia coli strains which are enteropathogens to small-bowel mucin Wanke, C.A.;S. Cronan;C. Goss;K. Chadee;R.L. Guerrant
  28. J. Infect. Dis. v.178 Successful treatment of diarrheae disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus Wanke, A.A.;J. Gerrior;V. Blais;H. Mayer;D. Acheson https://doi.org/10.1086/314443